The Jaén Hospital Invests €1.3 million in a New Hybrid Technology Operating Room

Andalusia continues to invest in health. The University Hospital of Jaén has invested €1.3 million in a new hybrid technology operating room aimed at performance in interventions in this specialty for complex cases. 

In addition, it will be used, occasionally, as an operating room to perform surgical techniques without the need for fluoroscopy, according to the statement from the Ministry of Health and Consumer Affairs.

If you want to read more about the new hybrid technology in which the University Hospital in Andalusia has recently invested, and find the latest financial news of the day, download for free our companion app Born2Invest.

The new hybrid technology will allow percutaneous and open vascular techniques to be carried out

Likewise, the territorial delegate of Health and Consumer Affairs, Elena González, highlighted that in the new operating room “1,200 procedures will be able to be carried out per year in this new area, which has had an execution period of forty days that has just been completed.” Of the total investment, €409,000 have been allocated to work and the rest, €871,000 , to equipment .

In the new hybrid technology operating room, percutaneous and open vascular techniques will be carried out, that is, combining ultrasound-guided, X-ray-guided procedures and conventional open techniques in the same patient, which will allow progress in surgical and endovascular resolution.

Likewise, many cardiovascular patients and patients with allergy problems to iodinated contrasts will be able to benefit from the new technology, which adapts to the patient’s conditions, allowing studies with Co2 as a contrast medium and fusion systems, avoiding CT scans after the procedure. Procedure which ensures the same and prevents new interventions .

The Andalusian Government will allocate a total of €14.27 billion in the 2024 Budgets for the Ministry of Health and Consumption

In this direction, the Andalusian Government will allocate in the 2024 Budgets a total of €14.27 billion for the Ministry of Health and Consumer Affairs, which represents 3% more compared to 2023 and 45% compared to 2018 . Thus, the accounts reflect an increase compared to five years ago of €4.4 billion for Andalusian public health.

In this sense, it is worth noting that the 2024 Budget project contemplates a per capita expenditure on health of €1,695.96. That means 4.1% more than in 2023 (€1,629) and 45.1% more than in 2018 (€1,169).

45.7% of the sector’s public health spending in 2021 originated in three autonomous communities: Catalonia, Andalusia and Madrid , with €14.02 billion, €12.64 billion and €10.35 billion, respectively. However, the communities that increased their spending the most compared to the figure from the last period were Murcia (8.4%), the Canary Islands (7.2%) and Andalusia (6.6%).

__

(Featured image by sasint via Pixabay)

DISCLAIMER: This article was written by a third party contributor and does not reflect the opinion of Born2Invest, its management, staff or its associates. Please review our disclaimer for more information.

This article may include forward-looking statements. These forward-looking statements generally are identified by the words “believe,” “project,” “estimate,” “become,” “plan,” “will,” and similar expressions. These forward-looking statements involve known and unknown risks as well as uncertainties, including those discussed in the following cautionary statements and elsewhere in this article and on this site. Although the Company may believe that its expectations are based on reasonable assumptions, the actual results that the Company may achieve may differ materially from any forward-looking statements, which reflect the opinions of the management of the Company only as of the date hereof. Additionally, please make sure to read these important disclosures.

First published in PlantaDoce. A third-party contributor translated and adapted the article from the original. In case of discrepancy, the original will prevail.

Although we made reasonable efforts to provide accurate translations, some parts may be incorrect. Born2Invest assumes no responsibility for errors, omissions or ambiguities in the translations provided on this website. Any person or entity relying on translated content does so at their own risk. Born2Invest is not responsible for losses caused by such reliance on the accuracy or reliability of translated information. If you wish to report an error or inaccuracy in the translation, we encourage you to contact us.